AzTrials
AzTrials

Prosthetic-joint InfectionNCT06427772

Incidence of Early Infection After Bipolar Hemiarthroplasty and Its Associated Factors in Fracture Neck of Femur

An observational study of Prosthetic-joint Infection, run by Assiut University.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Periprosthetic joint infections (PJI) following hemiarthroplasty for hip fractures are a catastrophic complication that results in severe worsening of patients' daily function and quality of life. The incidence of prosthetic joint infection (PJI) in hemiarthroplasty after femoral neck fracture varies from 2% to 17%. Read more about this study

Who is it for?
Any age
Conditions the study is for
Prosthetic-joint Infection
What is being tested?
bipolar hemiarthroplasty
Type of treatment
Surgery or procedure
How many people
74 participants
Where
No sites listed yet
Study dates
1 Jun 2024to 30 Jun 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Child, Adult, Older adult

Study population: * Study Setting: Department of Orthopedic and Trauma Surgery, Assiut University. * Study subjects: a. Inclusion criteria: * Patients with femoral neck fractures and treated by bipolar hemiarthroplasty. * Patients or their legal representative able to give informed consent. b. Exclusion criteria: * Patients that received HA secondary to a failed internal fixation of a femoral neck fracture. * Patients with a pathological fracture due to malignancy.

Who may be able to join

  • Patients with femoral neck fractures and treated by bipolar hemiarthroplasty.
  • Patients or their legal representative able to give informed consent.

Who cannot join

  • Patients that received HA secondary to a failed internal fixation of a femoral neck fracture.
  • Patients with a pathological fracture due to malignancy.

Trial locations and contacts

No sites are listed yet.

Ahmed Sallam AboElazaiem, bachelor's contact

01005732964

ahmedsallam2020159@gmail.com

About this study

Periprosthetic joint infections (PJI) following hemiarthroplasty for hip fractures are a catastrophic complication that results in severe worsening of patients' daily function and quality of life. The incidence of prosthetic joint infection (PJI) in hemiarthroplasty after femoral neck fracture varies from 2% to 17%. Identifying risk factors associated with early infection following HA for hip fractures may provide an opportunity to treat and prevent this potential complication with preoperative planning in many patients. So investigators will study the rate of early infection and its associated factor after bipolar hemiarthroplasty.

Read the detailed description

Femoral neck fractures (FNF) have a significant incidence and a rising trend worldwide. FNF is associated with a high mortality and disability rate, decreasing the independence and quality of life for affected patients. Acute displaced intracapsular femoral neck fractures account for about half of all hip fractures, with the majority of these fractures in older patients being treated surgically with hip hemiarthroplasty(HA), total hip arthroplasty, or internal fixation. Hemiarthroplasty is also used to treat femoral neck nonunion, failed screw fixation, and pathological femoral neck fracture. The treatment aims are to reduce pain, allow early mobilization, and restore the patient's pre-injury level of function while limiting perioperative surgical and medical complications. Patients with FNF frequently undergo hemiarthroplasty to restore joint biomechanics. Two types of implants are used in hemiarthroplasty: monopolar and bipolar . The bipolar implants have a polyethylene bearing between the stem and head of the endoprosthesis, which allows the components to rotate. There are debatable findings and a lack of consensus on the optimal component for hemiarthroplasty. Periprosthetic joint infections (PJI) following hemiarthroplasty for hip fractures are a catastrophic complication that results in severe worsening of patients' daily function and quality of life. The incidence of prosthetic joint infection (PJI) in hemiarthroplasty after femoral neck fracture varies from 2% to 17%. Identifying risk factors associated with early infection following HA for hip fractures may provide an opportunity to treat and prevent this potential complication with preoperative planning in many patients. So investigators will study the rate of early infection and its associated factor after bipolar hemiarthroplasty.

Being tested
bipolar hemiarthroplasty

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bipolar hemiarthroplastyProcedure or surgery

    bipolar hemiarthroplasty for neck femur fracture

Study groups in NCT06427772
Study groupRoleWhat they receive
group 1 diseased group(infected)the presence of persistent discharge after 7 days diagnostic for early infection follow up period first 4 week postoperative bipolar hemiarthroplasty in fracture neck of femur study the risk factors in this group
Receives: Procedure: bipolar hemiarthroplasty
group 2 : control group (normal )no infection after hemiarthroplasty follow up period first 4 week postoperative bipolar hemiarthroplasty in fracture neck of femur
Receives: Procedure: bipolar hemiarthroplasty

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence of early infection after bipolar hemiarthroplasty

    investigators will take all cases with bipolar hemiarthroplasty after femoral neck fracture then follow up them for 4 weeks. An infection was categorized as early, if it occurred within 4 weeks after surgery After that investigators will classify them to infected (disease group) and non infected (control group) and studying risk factor predisposing to early infection after HA.

    For diagnosis of infection : the presence of persistent discharge after 7 days

    Measured: 4 weeks postoperative

  2. risk factor predisposing to early infection after HA.1-preoperative parameters :Patient age

    Age in years

    Measured: preoperative evaluation 1 week

  3. risk factor predisposing to early infection after HA.1-preoperative parameters :sex

    male or female

    Measured: preoperative evaluation 1 week

  4. risk factor predisposing to early infection after HA.1-preoperative parameters :Chronic diseases as Diabetes, rheumatoid arthritis and other inflammatory or autoimmune arthritis.

    present or not

    Measured: preoperative evaluation 1 week

  5. risk factor predisposing to early infection after HA.1-preoperative parameters : • Active skin disease (at site of surgical incision)

    present or not

    Measured: preoperative evaluation 1 week

  6. risk factor predisposing to early infection after HA.1-preoperative parameters : • Smoking and alcohol consumption

    yes or no

    Measured: preoperative evaluation 1 week

  7. risk factor predisposing to early infection after HA.1-preoperative parameters : • Distant septic focus after arthroplasty as (pneumonia ,UTI ,abdominal ,oral and cutaneous infection).

    present or no

    Measured: preoperative evaluation 1 week

  8. risk factor predisposing to early infection after HA.2-intraoperative parameters : • Surgery time .

    in hours

    Measured: at time of operation

  9. risk factor predisposing to early infection after HA.2-intraoperative parameters :• Appropriate antibiotics prophalyxis and Need to blood transfusion.

    yes or no

    Measured: at time of operation

  10. risk factor predisposing to early infection after HA.3-postoperative parameters :• Persistent drainage after 7 days.

    time in days

    Measured: 1 week postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 May 2024
  2. Study start1 Jun 2024 (estimated)
  3. Primary completion1 Jun 2025 (estimated)
  4. Study completion30 Jun 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
74 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06427772
Sponsor's protocol ID
Sallam
Status last verified
May 2024
First submitted
15 May 2024
Last updated
24 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Prosthetic-joint Infection, run by Assiut University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 24 May 2024. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ahmed Sallam AboElazaiem, bachelor's (01005732964, ahmedsallam2020159@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence of early infection after bipolar hemiarthroplasty (time frame: 4 weeks postoperative). The study lists 10 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 24 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in